Johnson & Johnson announced plans to invest over 55 billion dollars in the United States over the next four years, marking a 25 percent increase compared to the previous four years. The investment includes four new manufacturing facilities, starting with a 2 billion dollar high-tech biologics plant in North Carolina, expected to support 5,000 construction jobs and create over 500 permanent positions.

The investment will also go toward expanding research and development, advancing technologies in areas such as oncology, immunology, and neuroscience, and improving drug discovery processes. Johnson & Johnson estimates its total U.S. economic impact will exceed 100 billion dollars annually.